Dimensional Fund Advisors’s Clover Health Investments CLOV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$16.5M Sell
3,148,626
-269,240
-8% -$914K ﹤0.01% 2121
2026
Q1
$6.01M Sell
3,417,866
-216,459
-6% -$470K ﹤0.01% 2444
2025
Q4
$8.54M Buy
3,634,325
+1,494,043
+70% +$4.08M ﹤0.01% 2340
2025
Q3
$6.55M Buy
2,140,282
+1,425,391
+199% +$4.07M ﹤0.01% 2457
2025
Q2
$1.99M Buy
714,891
+620,763
+659% +$2.04M ﹤0.01% 2762
2025
Q1
$338K Hold
94,128
﹤0.01% 3053
2024
Q4
$297K Hold
94,128
﹤0.01% 3111
2024
Q3
$265K Hold
94,128
﹤0.01% 3126
2024
Q2
$116K Hold
94,128
﹤0.01% 3233
2024
Q1
$74.7K Hold
94,128
﹤0.01% 3297
2023
Q4
$89.6K Hold
94,128
﹤0.01% 3287
2023
Q3
$102K Sell
94,128
-20,131
-18% -$23.9K ﹤0.01% 3312
2023
Q2
$103K Sell
114,259
-8,480
-7% -$7.52K ﹤0.01% 3319
2023
Q1
$104K Buy
+122,739
New +$134K ﹤0.01% 3296
2022
Q3
$693K Buy
+407,534
New +$1.07M ﹤0.01% 2973

Other funds holding CLOV

Dimensional Fund Advisors's CLOV Position: Q2 2026 in Review

Dimensional Fund Advisors reduced its Clover Health Investments (CLOV) stake by 7.9% in Q2 2026, selling an estimated $914K and leaving 3,148,626 shares worth $16.5M. The position accounts for ﹤0.01% of the portfolio, ranked #2121.

Dimensional Fund Advisors first reported a position in CLOV in Q3 2022 and has held it in 15 quarters since. 226 funds tracked by Wall St. Rank hold CLOV as of Q2 2026.

  • Dimensional Fund Advisors held 3,148,626 shares of Clover Health Investments worth $16.5M as of Q2 2026.
  • Dimensional Fund Advisors sold 269,240 Clover Health Investments shares in Q2 2026, an estimated $914K.
  • Clover Health Investments made up ﹤0.01% of Dimensional Fund Advisors's portfolio in Q2 2026, its #2121 holding.
  • Dimensional Fund Advisors first reported a position in Clover Health Investments in Q3 2022 and has held it in 15 quarters since.
  • 226 funds tracked by Wall St. Rank held Clover Health Investments as of Q2 2026.

Based on Dimensional Fund Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.